In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Advances in revascularisation strategies in patients with multivessel disease
Session

Event : ESC Congress 2019

Topic : Coronary Intervention

  • Session type : Advances in Science
  • Date : 01 September 2019
  • Time : 10:30 - 12:00

5 presentations in this session

State of the Art - Ten years after syntax: a surgeon's perspective

Event : ESC Congress 2019

  • Session : Advances in revascularisation strategies in patients with multivessel disease
  • Speaker : M Borger (Leipzig,DE)

Prognostic impact of SYNTAX Score in patients with myocardial infarction with multivessel coronary artery disease and cardiogenic shock: insight from the CULPRIT-SHOCK Trial

Event : ESC Congress 2019

  • Session : Advances in revascularisation strategies in patients with multivessel disease
  • Speaker : P Guedeney (Paris,FR)

Coronary artery bypass grafting vs. FFR-guided PCI in diabetic patients with multivessel disease

Event : ESC Congress 2019

  • Session : Advances in revascularisation strategies in patients with multivessel disease
  • Speaker : G Di Gioia (Aalst,BE)

Percutaneous coronary intervention in 2030: overcoming current PCI limitations

Event : ESC Congress 2019

  • Session : Advances in revascularisation strategies in patients with multivessel disease
  • Speaker : A Colombo (Milan,IT)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are